Skip To The Main Content

FDA Issues Regulatory Update for Health Professionals

The United States Food and Drug Administration (FDA) has issued an update on its regulatory activities aimed at health care professionals.  The update highlights the FDA 2017 year-end review and 2018 priorities, evaluation of nicotine replacement therapies, and new steps to improve generic drug reviews.  To read the FDA regulatory update for health care professionals, use the link below.